مقال بحثي وصول مفتوح
Oral cyclophosphamide treatment for clinical periocular inflammation of unknown origin
This study outlines a scenario involving unilateral periocular inflammation exhibited resistance to conventional immunomodulatory therapy (IMT) and biologic response modifying agents, which was successfully managed with oral cyclophosphamide monotherapy. A 39-year-old male visited our clinic, expressing discomfort and …